BEDMINSTER, N.J., and DUBLIN, Ireland, June 28, 2018 — Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that the last patient study visit has occurred in its potential landmark cardiovascular outcomes study, REDUCE-IT™.

Safety-net hospitals (SNHs) and smaller facilities were less likely to participate in the voluntary Bundled Payments for Care Improvement (BPCI) programs for cardiac services than larger centers with catheterization laboratories. These findings indicate that the outcomes observed from these programs may not be broadly applicable.

A new study published in Hypertension suggests tailoring blood pressure (BP) treatment to a patient’s exercise level may help, because people with elevated but controlled hypertension saw an increase in BP during physical activity.

About a quarter of those who require insulin to treat diabetes use less than what is prescribed because of cost concerns, suggests a single-center study presented last week at the American Diabetes Association scientific sessions in Orlando.

Frequent binge drinkers—particularly men—are more likely to have cardiovascular risk factors such as hypertension and high cholesterol, according to a new study published in the Journal of the American Heart Association.

UnitedHealthcare (UHC) will now cover the HeartFlow FFRct Analysis, a noninvasive technology that allows clinicians to view a simulated, three-dimensional model of a patient’s coronary blood flow.

A pair of point/counterpoint articles published online June 25 in JACC: Heart Failure debated whether the Hospital Readmissions Reduction Program (HRRP) has resulted in greater mortality for heart failure patients or whether those observations stem from incomplete or misconstrued evidence.

A triple therapy approach of warfarin, clopidogrel and aspirin substantially reduces the risk of ischemic stroke and stent thrombosis compared to dual antiplatelet therapy (DAPT), according to a meta-analysis of patients with atrial fibrillation (AFib) undergoing coronary stenting. However, the three-medication strategy is associated with a higher bleeding risk.

Extended reality technologies can be used to educate patients, their families and medical students about cardiac anatomy, facilitate pre-procedural planning and intraprocedural visualization, and serve as a rehabilitation tool for stroke survivors, according to a review published in JACC: Basic to Translational Science.

A novel positron emission tomography (PET) radiotracer could improve upon current methods for identifying bacterial heart infections, according to a presentation at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging in Philadelphia.